About this episode

Nasha Fitter discusses the advancements in FOXG1 gene therapy and the upcoming clinical trials.

FOXG1 Research Foundation CEO Nasha Fitter returns to Sounds of Science with extraordinary updates: FDA Fast Track designation, IND clearance, and the first‑ever clinical trial for a FOX G1 gene therapy now within reach. In this episode, hear how science, community, and a mother’s determination are rewriting what’s possible. Show Notes Cell and Gene Therapy CDMO Solutions | Charles River Viral Vector Manufacturing \ Charles River AAV Production for Rare Disease Therapies: From Challenge to Solution | Webcast Rare Disease | Charles River Rare Disease Research for Drug Development | Charles River FOX G1: A Mom’s Mission | Podcast

People in this episode

Host: Charles River

Guest: Nasha Fitter

Topics covered

• FOXG1
• gene therapy
• clinical trials
• FDA Fast Track
• rare diseases
• community support

Keywords

• FOXG1
• gene therapy
• clinical trial
• FDA Fast Track
• rare disease
• Nasha Fitter
• community support

Mentioned in this episode

Organizations: FOXG1 Research Foundation, FDA, Charles River

Books & works: FOX G1: A Mom’s Mission

More episodes of Sounds of Science

• Laboratory Biosecurity for Exotic Viruses · July 21, 2026 · 13 min
• From Cell Painting to Toxicology: Advancing Treatment for PACS2 Therapy · July 7, 2026 · 39 min

Explore listener stats, chart rankings, contacts and more on the Sounds of Science podcast page.